Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
scientific article published on 8 November 2011
Author/s
author: Xavier Castellsagué, Frank Struyf, Dan Apter, Jorge Salmerón, Anne Szarewski, Cosette M Wheeler, Jorma Paavonen, Francesc Xavier Bosch José, S. Rachel Skinner, Suzanne Marie Garland, Paulo Naud, Song-Nan Chow, Henry Kitchener, Unnop Jaisamrarn, Genara Limson, Barbara Romanowski, Fred Y Aoki, Willy A J Poppe, Toufik Zahaf, Dominique Descamps, HPV PATRICIA Study Group
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.